Recent News

• 03.12.2025 - Leerink's Global Healthcare Conference 2025| Fireside Chat
• 03.06.2025 - Arcturus Therapeutics Fourth Quarter and Full Year 2024 Earnings Call
• 03.06.2025 - Arcturus Therapeutics Fourth Quarter and Full Year 2024 Earnings Call
• 03.06.2025 - Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2024 Financial Update and Pipeline Progress
• 03.06.2025 - Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2024 Financial Update and Pipeline Progress
• 03.05.2025 - Arcturus Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
• 03.05.2025 - Arcturus Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
• 02.24.2025 - Arcturus Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 6, 2025
• 02.24.2025 - Arcturus Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 6, 2025
• 02.14.2025 - European Commission Approves CSL and Arcturus Therapeutics’ KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine

Recent Filings

• 02.05.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors